Application | Comment | Organism |
---|---|---|
drug development | therapeutic inhibition of IDO1 is receiving much attention due to its proposed role in the pathogenesis of several diseases including cancer, hypotension and neurodegenerative disorders | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression of His6-tagged IDO1 in Escherichia coli strain BL21 Star | Homo sapiens |
expression of His6-tagged IDO2 in Escherichia coli strain BL21 Star | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-([5-(3-methoxyphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)-N-(5-methyl-1,3-thiazol-2-yl)acetamide | poor inhibitor; poor inhibitor | Homo sapiens | |
methyl thiohydantoin-Trp | - |
Homo sapiens | |
additional information | no inhibition by phenylthiohydantoin-Trp; no inhibition by phenylthiohydantoin-Trp | Homo sapiens | |
N-(1,3-benzodioxol-5-yl)-2-([5-(4-methylphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)acetamide | a reversible inhibitor of IDO1. highly specific for IDO1 compared to IDO2, docking analysis with IDO1 and IDO2; a reversible inhibitor of IDO1. highly specific for IDO1 compared to IDO2, docking analysis with IDO1 and IDO2 | Homo sapiens | |
N-carbamoyl-2-([5-(4-methylphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)acetamide | poor inhibitor; poor inhibitor | Homo sapiens | |
N-methyl-L-Trp | - |
Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0141 | - |
L-tryptophan | pH 7.0, 22°C, IDO2 | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
D-tryptophan + O2 | Homo sapiens | - |
N-formyl-D-kynurenine | - |
? | |
L-tryptophan + O2 | Homo sapiens | - |
N-formyl-L-kynurenine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | F5H5G0 | IDO2 | - |
Homo sapiens | P14902 | IDO1 | - |
Purification (Comment) | Organism |
---|---|
recombinant His6-tagged IDO1 from Escherichia coli strain BL21 Star by nickel affinity chromatography and gel filtration | Homo sapiens |
recombinant His6-tagged IDO2 from Escherichia coli strain BL21 Star by nickel affinity chromatography and gel filtration | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
D-tryptophan + O2 | - |
Homo sapiens | N-formyl-D-kynurenine | - |
? | |
L-tryptophan + O2 | - |
Homo sapiens | N-formyl-L-kynurenine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
IDO1 | - |
Homo sapiens |
IDO2 | - |
Homo sapiens |
indoleamine 2,3-dioxygenase 1 | - |
Homo sapiens |
indoleamine 2,3-dioxygenase 2 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
22 | - |
assay at room temperature | Homo sapiens |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
1 | - |
L-tryptophan | pH 7.0, 22°C, IDO2 | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7 | - |
assay at | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.003 | - |
pH 7.0, 22°C, IDO1 | Homo sapiens | N-(1,3-benzodioxol-5-yl)-2-([5-(4-methylphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)acetamide | |
0.0216 | - |
pH 7.0, 22°C, IDO1 | Homo sapiens | methyl thiohydantoin-Trp | |
0.0826 | - |
pH 7.0, 22°C, IDO2 | Homo sapiens | methyl thiohydantoin-Trp | |
0.25 | - |
above, pH 7.0, 22°C, IDO1 | Homo sapiens | N-carbamoyl-2-([5-(4-methylphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)acetamide | |
0.25 | - |
above, pH 7.0, 22°C, IDO1 | Homo sapiens | 2-([5-(3-methoxyphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)-N-(5-methyl-1,3-thiazol-2-yl)acetamide | |
0.25 | - |
above, pH 7.0, 22°C, IDO2 | Homo sapiens | N-(1,3-benzodioxol-5-yl)-2-([5-(4-methylphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)acetamide | |
0.25 | - |
above, pH 7.0, 22°C, IDO2 | Homo sapiens | N-carbamoyl-2-([5-(4-methylphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)acetamide | |
0.25 | - |
above, pH 7.0, 22°C, IDO2 | Homo sapiens | 2-([5-(3-methoxyphenyl)[1,3]thiazolo[2,3-c][1,2,4]triazol-3-yl]sulfanyl)-N-(5-methyl-1,3-thiazol-2-yl)acetamide |
General Information | Comment | Organism |
---|---|---|
metabolism | indoleamine 2,3-dioxygenase catalyzes the first step in tryptophan breakdown along the kynurenine pathway | Homo sapiens |
additional information | IDO1 and IDO2 have different kinetic parameters and different inhibition profiles | Homo sapiens |
kcat/KM Value [1/mMs-1] | kcat/KM Value Maximum [1/mMs-1] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
4.5 | - |
L-tryptophan | pH 7.0, 22°C, IDO2 | Homo sapiens | |
70.9 | - |
L-tryptophan | pH 7.0, 22°C, IDO1 | Homo sapiens |